These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 18555634

  • 1. Significant differences in drug susceptibility among species in the Candida parapsilosis group.
    van Asbeck E, Clemons KV, Martinez M, Tong AJ, Stevens DA.
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):106-9. PubMed ID: 18555634
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.
    Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG.
    J Clin Microbiol; 2009 Aug; 47(8):2392-7. PubMed ID: 19494078
    [Abstract] [Full Text] [Related]

  • 6. Characterization of Candida parapsilosis complex isolates.
    de Toro M, Torres MJ, Maite R, Aznar J.
    Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
    Cordeiro RA, Macedo RB, Teixeira CEC, Marques FJF, Bandeira TJPG, Moreira JLB, Brilhante RSN, Rocha MFG, Sidrim JJC.
    J Med Microbiol; 2014 Jul; 63(Pt 7):936-944. PubMed ID: 24722799
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
    Szilágyi J, Földi R, Gesztelyi R, Bayegan S, Kardos G, Juhász B, Majoros L.
    Chemotherapy; 2012 Jul; 58(2):159-64. PubMed ID: 22626860
    [Abstract] [Full Text] [Related]

  • 14. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
    Cantón E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yagüe G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D, FUNGEMYCA Study Group.
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
    [Abstract] [Full Text] [Related]

  • 15. In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.
    Cantón E, Espinel-Ingroff A, Pemán J, del Castillo L.
    Antimicrob Agents Chemother; 2010 May; 54(5):2194-7. PubMed ID: 20145083
    [Abstract] [Full Text] [Related]

  • 16. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples.
    Ataides FS, Costa CR, Souza LK, Fernandes Od, Jesuino RS, Silva Mdo R.
    Rev Soc Bras Med Trop; 2015 May; 48(4):454-9. PubMed ID: 26312937
    [Abstract] [Full Text] [Related]

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 18. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
    Gonçalves SS, Amorim CS, Nucci M, Padovan AC, Briones MR, Melo AS, Colombo AL.
    Clin Microbiol Infect; 2010 Jul; 16(7):885-7. PubMed ID: 19686280
    [Abstract] [Full Text] [Related]

  • 19. Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.
    Khan Z, Ahmad S, Joseph L, Chandy R, Theyyathel A.
    J Chemother; 2011 Apr; 23(2):97-101. PubMed ID: 21571626
    [Abstract] [Full Text] [Related]

  • 20. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.
    Bonfietti LX, Martins MDA, Szeszs MW, Pukiskas SBS, Purisco SU, Pimentel FC, Pereira GH, Silva DC, Oliveira L, Melhem MSC.
    J Med Microbiol; 2012 Jul; 61(Pt 7):1003-1008. PubMed ID: 22493277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.